CervoMed Inc. Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31)
CervoMed Inc. (CRVO) reported Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) of 1.90% for the 10-month period ending 2017-11-01, per its 10-K filed 2018-04-02.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsRiskFreeInterestRate · last filed 2018-04-02
- CervoMed Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2017-03-31 was 2.10%.
| Period end | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 3 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 6 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 9 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 10 month |
|---|---|---|---|---|
| 2017-11-01 | 1.90% 10-K · filed 2018-04-02 | |||
| 2017-09-30 | 1.80% 10-Q · filed 2017-11-13 | |||
| 2017-06-30 | 1.90% 10-Q · filed 2017-08-14 | |||
| 2017-03-31 | 2.10% 10-Q · filed 2017-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |